Skip to content
Surprising Science

Stem Cell Eye Treatments

Blind patients suffering from a type of eye disease that strikes in childhood will become the second group of people in the world to receive stem cells left over from fertility treatment.
Sign up for the Smarter Faster newsletter
A weekly newsletter featuring the biggest ideas from the smartest people

The US Food and Drug Administration (FDA) has given the go-ahead for the controversial transplant of embryonic stem cells into the eyes of patients with Stargardt’s macular degeneration, where the light-sensitive retina cells at the back of eye are destroyed. The announcement follows the first injection of embryonic stem cells into a patient in the US who is partially paralysed as a result of a spinal cord injury. Last October, a US biotechnology company, Geron, announced the start of the first clinical trial of embryonic stem cells with the hope of repairing damaged nerves.

Sign up for the Smarter Faster newsletter
A weekly newsletter featuring the biggest ideas from the smartest people

Related
Advancements in stem cells, along with 3D printing technology, have applications in cosmetic safety testing, drug discovery and testing, organ and tissue printing, instant diagnosis and treatment, and so much more. Scientists recently found that baby teeth contain stem cells which can soon be used in these healthcare applications.  

Up Next